| Literature DB >> 21668680 |
Ariel Pereda1, Agustina Rimondi, Javier Cappuccio, Ramon Sanguinetti, Matthew Angel, Jianqiang Ye, Troy Sutton, Marina Dibárbora, Valeria Olivera, Maria I Craig, Maria Quiroga, Mariana Machuca, Andrea Ferrero, Carlos Perfumo, Daniel R Perez.
Abstract
In this report, we describe the occurrence of two novel swine influenza viruses (SIVs) in pigs in Argentina. These viruses are the result of two independent reassortment events between the H1N1 pandemic influenza virus (H1N1pdm) and human-like SIVs, showing the constant evolution of influenza viruses at the human-swine interface and the potential health risk of H1N1pdm as it appears to be maintained in the swine population. It must be noted that because of the lack of information regarding the circulation of SIVs in South America, we cannot discard the possibility that ancestors of the H1N1pdm or other SIVs have been present in this part of the world. More importantly, these findings suggest an ever-expanding geographic range of potential epicenters of influenza emergence with public health risks.Entities:
Mesh:
Year: 2011 PMID: 21668680 PMCID: PMC3175318 DOI: 10.1111/j.1750-2659.2011.00246.x
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Schematic table showing the lineages of reassortant swine viruses identified
| Virus | 1 (PB2) | 2 (PB1) | 3 (PA) | 4 (HA) | 5 (NP) | 6 (NA) | 7 (M) | 8 (NS) |
|---|---|---|---|---|---|---|---|---|
| Swine human‐like H1 | NA‐Av | Hu | NA‐Av | Hu | cH1N1 | Hu | cH1N1 | cH1N1 |
| H1N1 2009 pdm | NA‐Av | Hu | NA‐Av | cH1N1 | cH1N1 | EA‐Sw | EA‐Sw | cH1N1 |
| BsAs/H1N1 | NA‐Av (93–95%) | Hu (84–85%) | NA‐Av (90–92%) | Hu (92–97%) | cH1N1 (93–96%) | Hu (89–92%) | EA‐Sw (91–95%) | cH1N1 (92–96%) |
| StaFe/H1N2 | NA‐Av (93–95%) | Hu (83–84%) | NA‐Av (90–92%) | Hu (93–95%) | cH1N1 (94–96%) | Hu (91–93%) | EA‐Sw (89–94%) | cH1N1 (92–96%) |
Virus lineages are identified in each box.
In between parenthesis are the ranges of percentages of identity of the two reassortants to each lineage.
NA‐Av, North America Avian; Hu, Human; EA‐Sw, Eurasian Swine; cH1N1, classical swine H1N1; HA, hemagglutinin.
Figure 1Hemagglutination inhibition (HI) assay with sera against antigenically distinct swine influenza viruses and human influenza viruses. Y‐axis: HI titer; X‐axis: Antibodies used for HI assay in this study include ferret sera against human seasonal strain A/Brisbane/59/2007 (H1N1); swine sera against H1N1pdm strain A/California/04/2009 (H1N1), A/Mexico/4108/09 (H1N1), A/swine/Iowa/15/1930 (H1N1) (classical swine H1), A/swine/Minnesota/27866/99 (H1N1) (α cluster swine H1), A/ swine/Iowa/00239/04 H1N1 (β cluster swine H1), A/swine/Ohio/511445/07 (H1N1) (γ cluster swine H1), A/swine/Texas/01976/08 (H1N2) (δ1 cluster swine H1, Human‐Like lineage), A/Swine/Minnesota/07002083/07 (H1N1) (δ2 cluster swine H1 Human‐Like lineage), and A/swine/Texas/4199‐2/98 (H3N2).